Hillman Foundation’s very first grants supported better healthcare for southwestern Pennsylvanians. Today, with renowned research universities and outstanding hospitals, Pittsburgh has emerged as one of the leading healthcare centers in the world. Premier care enhances the quality of life for the region’s residents as well as for those who come here seeking advanced treatment not available anywhere else. Healthcare now represents a significant segment of southwestern Pennsylvania’s economy, providing employment, attracting top physicians and scientists, and generating investment in research and technology.
     Through its ongoing support of Hillman Cancer Center and establishment of the Hillman Fellows Program for Innovative Cancer Research, the Foundation has expanded its commitment to supporting the development of new cancer treatments.
     Hillman Cancer Center opened in 2002 on the campus of UPMC Shadyside. Combining patient care and research facilities under one roof, the building was the first permanent home of the University of Pittsburgh Cancer Institute (UPCI), designated by the National Cancer Institute as the only comprehensive cancer center in western Pennsylvania.
     In 2006 Hillman Foundation joined with the Henry L. Hillman Foundation to establish the Hillman Fellows Program for Innovative Cancer Research. The $20 million contribution provides seed money for scientists to carry their investigations into new, uncharted territory.
     Additional key investments in health and medicine by Hillman Foundation have been endowed chairs and the Hillman Pediatric Transplant Center at Children’s Hospital of Pittsburgh.

Hillman Cancer Center

Hillman Cancer Center opened in 2002 on the campus of UPMC Shadyside. Combining patient care and research facilities under one roof, the building was the first permanent home of the University of Pittsburgh Cancer Institute (UPCI), designated by the National Cancer Institute as the only comprehensive cancer center in western Pennsylvania. UPCI Director Ronald B. Herberman, MD, described Hillman Cancer Center as “a quantum improvement” in cancer care and investigation, offering “enormous potential to create the critical mass to cure cancer.”